Table 1. Summary of large series reporting on long-term outcome after Y90-radioembolization.
| Intermediate Stage | Branch PVT | Main PVT | Branch or Main PVT | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Reference | Child | N | OS (95%CI) | N | OS (95%CI) | N | OS (95%CI) | N | OS (95%CI) |
| Hilgard 2010 (N=108) | A/B | 51 | 16.4 (12.1-n.c.) | 33 | 10 (6-n.c.) | ||||
| Salem 2010 (N=291) | A B |
48 35 |
17.3 (13.7-32.5) 13.5 (6.4-25.4) |
19 | 16.6 (8.8-24) | 16 | 7.7 (3.3-13.2) | 35 57 |
10.4 (7.2-16.6) 5.6 (4.5-6.7) |
| 27 | 6.5 (5-8.5) | 30 | 4.5 (2.9-6.6) | ||||||
| Sangro 2011 (N=325) * | A B |
82 5 |
18.4 (13.6-23.2) 3.6 (2.4-10.8) |
44 | 10.7 (8.3-17.1) | 32 | 9.7 (4.8-11.8) | 76 | 10.2 (7.7-11.8) |
| Mazzaferro 2012 (N=51) | A B |
15 2 |
18(13-38) -- |
23 6 |
17(13-21) 8(5-10) |
5 1 |
9 (4-n.c.) 5 |
||
OS: overall survival (months). n.c. not calculable.
*
Unpublished data for branch and main PVT cohorts provided by authors.